By Kaywen Z
The Base Medical and Health Insurance/Takaful (Base MHIT) Plan is a new initiative by Bank Negara Malaysia, the Ministry of Finance, and the Ministry of Health. It is part of a broader effort to address medical inflation and strengthen Malaysia’s healthcare system.
Set out in a recent White Paper, the Base MHIT Plan proposes a standardised baseline insurance product alongside structural reforms within Malaysia’s private healthcare system.
The plan has been widely discussed as an affordability measure, defined by standardised benefits, published premium ranges, and clearer coverage limits. But the White Paper signals a deeper ambition: to shape how healthcare is financed and delivered, not merely how it is insured.
The most consequential part of the White Paper is not the product design, but the proposed shift in how private healthcare is paid for — specifically, the gradual move away from fee-for-service (FFS) billing toward Diagnosis-Related Group (DRG)–based payments. This shift goes to the heart of Malaysia’s private healthcare cost problem.
The Current State: Why the System Keeps Getting More Expensive
Currently, private healthcare in Malaysia operates largely on a fee-for-service (FFS) basis.
Under this model, providers are paid item-by-item—each consultation, test, procedure, and hospital day is billed separately. The incentive is straightforward: more billable activity generates more revenue. This model structurally rewards volume and intensity.
Insurers absorb these costs until premiums rise beyond what households can sustain. When coverage becomes unaffordable, patients downgrade or lapse their policies, as illustrated by the widely cited figure of 340,000 policy surrenders/cancellations between January 2024 and June 2025 referenced in discussions around the White Paper.
The public system ultimately bears the burden of complex cases. This cycle keeps repeating, making healthcare more expensive over time.
The proposed Base MHIT Plan acknowledges this reality. While standardised benefits and cost-sharing features may moderate cost growth at the margins, the White Paper’s underlying message is that medical inflation cannot be managed sustainably without changing provider incentives and payment dynamics.
The Proposed Solution: DRG Payments
The plan suggests moving toward a Diagnosis-Related Group (DRG) payment system. Under the DRG model, instead of billing item by item, hospitals are paid a fixed amount per case based on the diagnosis and severity.
Example: Treating pneumonia would be paid as a single bundled “episode,” not as a long list of charges. This encourages hospitals to be more efficient and coordinate care better.
As the payer pays a pre-set case amount linked to the diagnosis rather than reimbursing every line item, the hospital bears more of the risk of inefficiency, which makes efficiency and care coordination financially relevant.
Countries like the US, Germany, France, Sweden, Thailand, and China already use DRG systems in some form.
Across these systems, DRG has often been associated with improved cost transparency and better discipline over inpatient cost growth, but typically only when paired with strong governance.
The Good, the Bad, and the Ugly
The Good: Easier to predict and control costs. Encourages efficiency instead of unnecessary procedures. Makes insurance premiums more stable.
The appeal of DRG is obvious. Compared to open-ended fee-for-service billing, DRG makes inpatient care easier to benchmark and price: it turns an admission into a priced episode, strengthens incentives for operational efficiency, and reduces the structural reward for simply doing more billable activity. This translates into more predictable claims trends and less reliance on repeated premium repricing as the primary cost-control tool.
However, DRG is not inherently superior. It changes incentives, and incentives always create trade-offs. Once payment depends on diagnosis and severity, hospitals may have reason to optimise coding and, in weaker systems, to game or “upcode” into higher-paying groups unless audits are credible.
In practice, cost pressure can also result in shorter stays that reflect genuine efficiency gains — or premature discharges that reappear as readmissions and cause downstream complications.
DRG also struggles most where spending is highest: complex cases such as cancer care, multimorbidity, prolonged ICU stays often do not fit neatly into standard bundles, which is why functioning DRG systems typically require carve-outs, outlier payments, or stop-loss mechanisms to avoid penalising hospitals that take in complex patient cases.
What could potentially turn this payment reform “ugly” is governance failure. If rates are set without transparency, audits are inconsistent, or exceptions proliferate under provider pressure, DRG becomes symbolic rather than structural, and the system simply shifts from “bill inflation” to “code inflation.”
For private healthcare providers in Malaysia, this transition is not just a billing tweak but a reset of operating economics: it demands significant investment in documentation and coding capability, internal costing, and case management, while compressing margins for hospitals reliant on wide charging discretion.
The result, if poorly managed, is a new friction layer: administrative disputes, selective avoidance of complex outlier cases, and quiet rationing at the margins, without delivering sustained affordability.
Malaysia’s Real Challenge
The White Paper suggests rolling out DRG slowly, starting with common and predictable cases within defined hospital networks. That sequencing is sensible, but international experience suggests that design is the easy part.
The real challenge is whether Malaysia is prepared to:
• Set and enforce fair, transparent rates.
• Audit hospitals properly.
• Monitor patient outcomes (like readmissions and complications).
• Resist pressure from powerful providers.
Without strong enforcement, DRG risks becoming just another technical appendix rather than the engine of reform.
The Bottom Line
The Base MHIT Plan is not merely an insurance product. It is an attempt to stabilise a private healthcare system that has been drifting toward unsustainability. Its success does not hinge only on whether RM100,000 is the right coverage limit but on whether Malaysia can follow through on payment reform when it becomes politically uncomfortable.
With strong governance, DRG could help address upstream incentives, thus making healthcare more affordable. If not, it may simply become another recalibration before costs resume their climb, and this reform will fade like many before it.
In short: The plan isn’t just about cheaper insurance—it’s about fixing the way healthcare money flows, so affordability can be sustained in the long run.
WE